NorthWest Biotherapeutics Inc (NWBO)

[beartrap12]

Absolutely agree, Beach. I just want to add, Direct is “the same” as L, according to Linda and I agree. It’s part of this platform treatment, but for inoperable cancers. So it will quickly become part of the approvals. May take a few months or a year, as you point out.I think it will be used in the application for all solid tumors because of the data it has collected. I suspect they may run a second trial just to confirm times of treatment, etc. which were proven to be important in the first trial for efficacy. Remember , Method A vs. method B.
Great times ahead for patients and investors!

I also believe that D will be approved so much quicker than most believe as it’s action will be distinguished within a matter of months.